Stock listing
NOVOB Stock Price, News, Filings & Events — Novo Nordisk A/s Class B
Selected listing: NOVOB · OMXCOP · DKK · DK
This page tracks Novo Nordisk A/s Class B's NOVOB:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NOVOB:OMXCOP. NOVOB:OMXCOP is the stock-level entry point for investors researching Novo Nordisk A/s Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novo Nordisk A/S Class B is a leading global healthcare company based in Denmark, specializing in diabetes care and hormone replacement therapies. With a market capitalization of approximately 227.3 billion DKK, the company is recognized for its commitment to innovation and improving patient outcomes. Novo Nordisk is publicly traded under the ticker NOVO B.
- Ticker
- NOVO_B:OMXCOP
- Asset type
- Stock
- Market cap
- $203.52B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXCOP
- Currency
- DKK
Novo Nordisk A/s Class B NOVOB:OMXCOP stock context
This page tracks Novo Nordisk A/s Class B's NOVOB:OMXCOP listing on OMXCOP in DKK for DK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NOVOB:OMXCOP. NOVOB:OMXCOP is the stock-level entry point for investors researching Novo Nordisk A/s Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novo Nordisk A/S Class B is a leading global healthcare company based in Denmark, specializing in diabetes care and hormone replacement therapies. With a market capitalization of approximately 227.3 billion DKK, the company is recognized for its commitment to innovation and improving patient outcomes. Novo Nordisk is publicly traded under the ticker NOVO B.
Latest news from Novo Nordisk A/s Class B
Novo Nordisk A/S: IT Security incident at Novo Nordisk
June 11, 2026
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
June 11, 2026
Novo Nordisk introduces updated Rybelsus® tablet formulation in Canada for adults living with type 2 diabetes
June 9, 2026
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
June 3, 2026
Novo Nordisk advances cardiometabolic pipeline with new data featuring CagriSema and zenagamtide at the American Diabetes Association's 2...
May 27, 2026
Novo Nordisk A/s Class B earnings calls
Novo Nordisk A/S (NVO) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Novo Nordisk A/S (NVO) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Novo Nordisk A/S (NVO) Q4 2025 Earnings Call
February 4, 2026 · Replay with transcript and chapters
Novo Nordisk A/S (NVO) Q3 2025 Earnings Call
November 5, 2025 · Replay with transcript and chapters
Novo Nordisk A/S (NVO) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Novo Nordisk A/S (NVO) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Novo Nordisk A/s Class B
Novo Nordisk A/s Class B investor report
Review AI stock analysis and investor report context for NOVOB:OMXCOP.
Novo Nordisk A/s Class B company profile
View the public company page for Novo Nordisk A/s Class B on 6ix.
Novo Nordisk A/s Class B news
Read company news and market updates connected to Novo Nordisk A/s Class B.
Novo Nordisk A/s Class B investor events
Find investor webinars, events, and replay context for Novo Nordisk A/s Class B.
Alternate listings
NVO:NYSE
US · USD
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOV:XETR
DE · EUR
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOV:GETTEX
DE · EUR
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOV:TRADEGATE
DE · EUR
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOVO:TSX
CA · CAD
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
A3EU6F:LSX
DE · EUR
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOVOBC:AQUISEU
GB · DKK
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOVOB80:SET
TH · THB
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NOVA:GETTEX
DE · EUR
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
0QIU:LSIN
GB · DKK
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NONOF:OTC
US · USD
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.
NVON:BMV
MX · MXN
Alternate listing for Novo Nordisk A/s Class B; the primary context on this page is NOVOB:OMXCOP.